Qiagen NV

Healthcare · Diagnostics & Research

44.20$ -0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Qiagen NV (QGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 6,296 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet QGEN
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	66	79	107	148	230	357	455	552	715	765	1,212	2,775	2,885	3,796	3,914	3,756	4,126	4,088	4,454	4,190	4,308	5,039	5,748	5,236	5,870	6,147	6,288	6,115	5,690	6,296
Current Assets	49	59	74	97	141	177	193	259	387	370	683	648	704	1,333	1,365	748	993	921	1,095	962	1,038	1,648	2,155	1,570	1,624	2,110	2,394	2,148	1,960	1,995
Cash	2.0	4.3	6.3	12	22	56	45	99	196	192	430	347	333	826	855	228	402	333	396	293	439	658	1,184	624	598	881	731	668	664	839
Cash & Short-Term Investments	30	30	30	44	59	79	56	106	227	207	483	350	333	866	934	283	492	383	580	423	532	1,017	1,419	753	715	1,065	1,418	1,058	1,153	1,099
Receivables	7.0	10	18	22	41	46	58	70	74	72	88	153	179	237	249	274	307	334	310	326	302	369	398	485	487	470	434	516	459	403
Inventory	9.9	15	20	22	29	32	56	65	60	54	64	88	109	131	127	132	135	128	132	137	137	156	163	171	291	328	358	398	279	302
Property, Plant & Equipment	–	–	–	–	71	160	212	233	217	195	221	283	290	317	346	372	419	445	428	443	437	494	512	513	662	638	587	–	–	–
Goodwill	–	–	–	–	–	–	26	30,117	56	94	160	1,108	1,152	1,337	1,352	1,734	1,760	1,856	1,888	1,876	1,926	2,013	2,109	2,141	2,364	2,351	2,353	2,476	2,425	2,701
Intangible Assets	0.9	1.8	4.6	8.7	7.1	7.1	38	45	91	168	118	639	640	752	753	819	854	790	727	636	557	499	475	632	726	627	545	527	304	386
Total Liabilities	19	25	34	55	66	144	191	217	314	315	646	1,383	1,431	1,505	1,438	1,199	1,402	1,365	1,796	1,628	1,701	2,498	3,113	2,699	3,072	3,050	2,821	2,307	2,122	2,518
Current Liabilities	13	20	28	40	43	58	81	95	88	92	117	166	262	376	388	482	300	337	432	268	308	325	972	951	572	1,517	975	1,079	544	512
Short-Term Debt	3.2	5.3	9.1	18	9.4	8.5	3.3	9.2	8.0	6.9	7.4	2.8	28	53	79	148	5.2	4.9	132	0.9	1.0	1.4	503	304	66	870	412	610	78	–
Accounts Payable	5.6	6.7	9.2	11	19	20	24	19	20	16	24	40	49	44	48	60	51	51	46	52	51	59	69	85	118	101	99	84	83	73
Long-Term Debt	–	–	–	–	22	81	107	114	211	203	502	983	951	899	821	446	862	857	1,045	1,049	1,067	1,758	1,671	1,421	1,880	1,094	1,472	922	1,338	1,654
Shareholders' Equity	48	54	73	92	164	213	263	335	400	450	566	1,392	1,454	2,291	2,476	2,548	2,715	2,714	2,584	2,560	2,607	2,541	2,635	2,537	2,798	3,097	3,467	3,808	3,567	3,778
Retained Earnings	7.8	17	26	38	60	97	120	163	212	274	345	389	478	616	760	856	985	1,054	929	1,228	930	1,027	1,380	1,178	1,323	1,792	2,160	2,457	2,448	2,748
Shares Outstanding	102	121	141	134	140	140	140	142	143	145	148	169	197	206	232	230	232	233	233	228	230	233	233	220	227	225	223	217	218	208

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings